CytRx Corp. buy melinda
Start price
08.08.17
/
50%
€3.52
Target price
20.09.17
€4.33
Performance (%)
-30.90%
End price
20.09.17
€2.44
Summary
This prediction ended on 20.09.17 with a price of €2.44. The BUY prediction by melinda for CytRx Corp. performed very badly with a performance of -30.90%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% | 57.846% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% | 93.736% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% | 51.788% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% | 61.648% |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$
(Vom Mitglied beendet)